TMDX TransMedics
- 144.560
- -3.720-2.51%
- 154.100
- +9.540+6.60%
TransMedics News
TransMedics Gr Analyst Ratings
Baird Initiates TransMedics(TMDX.US) With Buy Rating, Announces Target Price $200
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $175
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Raises Target Price to $180
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $200
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $200
Oppenheimer Reaffirms Their Buy Rating on TransMedics Group (TMDX)
Needham Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $208
TransMedics Gr Analyst Ratings
Needham Initiates TransMedics(TMDX.US) With Buy Rating, Announces Target Price $208
Needham Initiates TransMedics Group at Buy With $208 Price Target
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), United Therapeutics (UTHR) and Regeneron (REGN)
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $200
CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $169
TransMedics Gr Analyst Ratings
Stephens & Co. Maintains Overweight on TransMedics Gr, Raises Price Target to $178
A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $153 to $200
TransMedics Gr Analyst Ratings
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $175
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Raises Target Price to $200
Analysis
Price Target
No Data
No Data